Use of blinatumomab as bridge therapy before allogeneic bone marrow transplantation in patients with acute b-lymphoblastic leukemia (b-all)

dc.contributor.author	Dubina, M.
dc.contributor.author	Iskrou, I.
dc.contributor.author	Lendzina, I.
dc.contributor.author	Kabayeva, K.
dc.date.accessioned	2025-06-16T13:46:47Z
dc.date.available	2025-06-16T13:46:47Z
dc.date.issued	2024
dc.identifier.uri	https://rep.bsmu.by/handle/BSMU/49411
dc.description	Use of blinatumomab as bridge therapy before allogeneic bone marrow transplantation in patients with acute b-lymphoblastic leukemia (b-all) / M. Dubina, I. Iskrou, I. Lendzina, K. Kabayeva // HemaSphere. – 2024. – Vol. 8, suppl. 1 [EHA 2024 : 29th Hybrid Congr. of the Europ. Hematology Assoc., Madrid, 13-16 June 2024 : abstr. book]. – P. 4471–4472. – URL: https://onlinelibrary.wiley.com/toc/25729241/2024/8/S1	ru_RU
dc.language.iso	en	ru_RU
dc.title	Use of blinatumomab as bridge therapy before allogeneic bone marrow transplantation in patients with acute b-lymphoblastic leukemia (b-all)	ru_RU
dc.type	Article	ru_RU